Israeli Based Biotech Company Clearmind Medicine Inc's CEO,

Tel Aviv, Israel / Vancouver, Canada, Dec. 15, 2022 (GLOBE NEWSWIRE) --  Clearmind Medicine Inc. (Nasdaq, CSE: CMND) (FSE: CWY) (“Clearmind” or the...

Related Keywords

Jerusalem ,Israel General ,Israel ,India ,United Kingdom ,Canada ,Tel Aviv ,Frankfurt ,Brandenburg ,Germany ,Canadian ,British ,Mark Weiser ,Adi Zuloff Shani ,John Krystal ,Nicholas Kadysh ,Scisparc Ltd ,Bar Ilan University Israel ,Clearmind Medicine Inc ,Frankfurt Stock Exchange ,Nasdaq ,Exchange Commission ,Clearmind Medicine Inc Nasdaq ,University Of British Columbia ,Hebrew University Of Jerusalem ,Psychiatry Department ,Canadian Securities Exchange ,Milan Research ,Sheba Medical Centre ,Development Company ,Gonda Multidisciplinary Brain Research Center ,Medicine Inc ,Fellow Shareholders ,Alcohol Use Disorder ,Hebrew University ,Bar Ilan University ,Bar Ilan Research ,Christian Sch ,British Columbia ,Nasdaq Capital Market ,Zuloff Shani ,Clearmind Medicine ,Private Securities Litigation Reform Act ,Nasdaq Cmnd ,Learmind Medicine Inc ,Letter To Shareholders ,